regionbassenormandie

Fédération des registres de cancers de Basse-Normandie

inca
CHUcaen
invs
baclesse
CHPC

université de caen


Contacter le webmaster
Copyright© 2008| Date de mise à jour:

Publication du registre digestif du calvados

  • Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinié F, Danzon A, Bara S, Bouvier AM, Trétarre B, Binder-Foucard F, Colonna M, Daubisse L, Hédelin G, Launoy G, Le Stang N, Maynadié M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Chérié-Challine L, Estève J, Remontet L, Velten M. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-75. Epub 2008 Jun 10.
  • Dejardin O, Bouvier AM, Faivre J, Boutreux S, De Pouvourville G, Launoy G. Access to care, socioeconomic deprivation and colon cancer survival. Aliment Pharmacol Ther. 2008 May;27(10):940-9.
  • Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, Guizard AV, Tretarre B, Launoy G, Colonna M, Danzon A, Molinie F, Troussard X, Bourdon-Raverdy N, Carli PM, Jaffré A, Bessaguet C, Sauleau E, Schvartz C, Arveux P, Maynadié M, Grosclaude P, Estève J, Faivre J. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer. 2007 Jan;43(1):149-60.
  • Blais S, Dejardin O, Boutreux S, Launoy G. Social determinants of access to reference care centres for patients with colorectal cancer--a multilevel analysis. Eur J Cancer. 2006 Nov;42(17):3041-8.
  • Dejardin O, Remontet L, Bouvier AM, Danzon A, Trétarre B, Delafosse P, Molinié F, Maarouf N, Velten M, Sauleau EA, Bourdon-Raverdy N, Grosclaude P, Boutreux S, De Pouvourville G, Launoy G. Socioeconomic and geographic determinants of survival of patients with digestive cancer in France. Br J Cancer. 2006 Oct 9;95(7):944-9.
  • Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G. omparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007 Feb;56(2):210-4.
  • Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006 Apr;93(4):465-74.
  • Dejardin O, Bouvier AM, Herbert C, Velten M, Buemi A, Delafosse P, Maarouf N, Boutreux S, Launoy G. Social and geographic disparities in access to reference care site for patients with colorectal cancer in France. Br J Cancer. 2005 May 23;92(10):1842-5.
  • Ciccolallo L, Capocaccia R, Coleman MP, Berrino F, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Møller H, Ponz de Leon M, Launoy G, Raverdy N, Williams EM, Gatta G. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut. 2005 Feb;54(2):268-73.
  • Bouvier V, Reaud JM, Gignoux M, Launoy G. Cost of diagnostic and therapeutic management of colorectal cancer according to stage at diagnosis in the Calvados Département, France. Eur J Health Econ. 2003;4(2):102-6.
  • Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut. 2004 Sep;53(9):1322-8.
  • Berchi C, Bouvier V, Réaud JM, Launoy G. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France. Health Econ. 2004 Mar;13(3):227-38.